What is in2being?
Established in 2010, in2being operates as a specialized consultancy and development partner for the medical device industry. The firm provides a comprehensive suite of services designed to mitigate the risks inherent in product development, including regulatory clearance, intellectual property strategy, and project rescue operations. With a portfolio encompassing over 175 successful client engagements, in2being serves as a vital intermediary that helps innovators navigate the complex FDA landscape. Their market position is defined by a unique ability to transform early-stage prototypes into market-ready medical solutions, effectively acting as an outsourced R&D and regulatory department for emerging healthcare companies.
How much funding has in2being raised?
in2being has raised a total of $410K across 1 funding round:
Debt
$410K
Debt (2024): $410K, investors not publicly disclosed
Key Investors in in2being
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for in2being?
With this latest injection of capital, in2being is well-positioned to expand its service capacity and deepen its technical expertise in emerging medical technologies. The firm is expected to leverage these resources to enhance its regulatory support infrastructure, potentially shortening the time-to-market for its diverse client base. As the medical device sector faces increasing scrutiny and complexity, in2being's strategic focus on project rescue and end-to-end development will likely remain a high-demand service. Future growth will likely center on scaling their internal team of experts and potentially integrating advanced digital health capabilities to maintain their competitive edge in the evolving healthcare innovation landscape.
See full in2being company page
